eXmoor pharma, a full-service cell and gene therapy (CGT) manufacturing partner, launched a new cell and gene therapy GMP facility to support the simultaneous production of multiple therapies for clinical trials. The 65,000 sq ft facility offers much-needed capacity and capability to help scale the next generation of CGTs for human trials and beyond. The facility is the final step in eXmoor’s expansion into a full-service CGT contract development and manufacturing organization (CDMO). The cel...